Publications

Balancing IL-17–mediated protection and IFN-γ–driven pathology at mucocutaneous barriers

 45
Balancing IL-17–mediated protection and IFN-γ–driven pathology at mucocutaneous barriers

Tags:

Previous Article

Astrocytes are critical for fear memory

Next Article

Controlling mucocutaneous barriers by cytokines

Related Posts

Generalized pustular psoriasis: immunological mechanisms, genetics, and emerging therapeutics

Generalized pustular psoriasis: immunological mechanism...

 109

Microglia depletion reduces human neuronal APOE4-related pathologies in a chimeric Alzheimer’s disease model

Microglia depletion reduces human neuronal APOE4-relate...

 125

Schizophrenia-related Xpo7 haploinsufficiency leads to behavioral and nuclear transport pathologies

Schizophrenia-related Xpo7 haploinsufficiency leads to ...

 59